Description of the medicine: Uralit-U (Uralyt-U)
URALIT-U (Uralyt-U) [The name of the drug is Madaus AG].
Granules containing potassium citrate, sodium citrate, citric acid.
The drug is designed to weaken the acid reaction of urine, the dissolution of uric acid-containing calculi.
It is used to dissolve stones consisting of urates and to prevent their subsequent formation (relapse prevention); for maintenance treatment in the presence of cystine stones and with cystinuria. The drug does not dissolve oxalate (consisting of calcium oxalate) and phosphate (consisting of calcium phosphate) calculi.
Uralit-U is also used to alkalize urine in the treatment of cytotoxic drugs and in late porphyria.
Take the drug daily, usually at a dose of 10 g (4 scoops) 3 times a day, after meals: in the morning and afternoon, 1 scoop, in the evening - two. The granulate is dissolved in a glass of boiled cooled water.
For effective treatment, a certain pH of urine should be maintained: with urate stones 6, 2 - 6, 8; with cystine stones 7, 5 - 8, 5; during cytostatic therapy, at least 7, 0; with late porphyria 7, 2 - 7, 5.
Determining the dose of the drug necessary to maintain urine pH within the specified limits is performed using the attached indicator papers (see Magurlit). The color shade of a strip of paper moistened with urine is compared with the color table and, depending on the results, increase or decrease subsequent doses of the drug. Determine the pH immediately before taking the drug.
To determine the pH of urine in the treatment of patients with cystine stones and late porphyria, special indicator paper is used.
The drug is usually well tolerated. Possible side effects and contraindications are the same as for magurlite.
Release form: in the form of granules of 280 g per package with indicator papers, a color table.